Cardiovascular-related deaths in prevalent dialysis patients are common. The long interdialytic interval, commonly referred to as the 2-day “Killer Gap,” is a time of heightened risk of mortality and morbidity with conventional hemodialysis. Multiple randomized clinical trials show intensive hemodialysis significantly reduces left ventricular mass and more frequent hemodialysis has associated with lower risk of cardiovascular-related hospitalizations.